. Author manuscript; available in PMC: 2019 Mar 1.

Published in final edited form as: Inflamm Intest Dis. 2017 Nov 18;2(3):147–153. doi: 10.1159/000484347

Table 2. Medications ever used at baseline by patients with inflammatory bowel disease.

Medication (%)	White (n=5223)	U.S. Born Asian (n=35)	Asian Immigrant (n=81)	p value
Oral mesalamine	78	77	79	0.988
Oral steroids	85	84	76	0.106
Thiopurines	66	61	56	0.119
Methotrexate	18	9	16	0.353
Anti-TNF agents	61	34	42	<0.001
Vedolizumab	3	0	0	0.626
Ustekinumab	1	0	0	0.897
Narcotics	46	29	25	<0.001